fda lumipulse - Search News

News

1st blood test for Alzheimer's disease approved by FDA

Medical Device Network · 1h

FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s

The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD) test.

The Washington Post on MSN · 2d

FDA endorses first-of-its-kind blood test for Alzheimer’s disease

The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less risky for patients with cognitive decline.

Express Healthcare · 3h

FDA approves first blood test to support Alzheimer’s diagnosis

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood test

1don MSN

FDA greenlights first blood test to diagnose Alzheimer's disease

FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.

1don MSN

New Alzheimer's Test Approved by FDA—What to Know

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results